Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 24, Issue 6, pp. 1389-1401
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 10, 2017
- Revision received October 11, 2017
- Accepted December 14, 2017
- Published first December 20, 2017.
Article Versions
- Previous version (December 20, 2017 - 06:53).
- Previous version (February 13, 2018 - 07:53).
- You are viewing the most recent version of this article.
Copyright & Usage
©2017 American Association for Cancer Research.
Author Information
- Douglass W. Tucker1,
- Christopher R. Getchell1,
- Eric T. McCarthy1,
- Anders W. Ohman1,
- Naoko Sasamoto2,
- Shuyun Xu3,
- Joo Yeon Ko4,
- Mamta Gupta2,
- Amy Shafrir2,
- Jamie E. Medina1,
- Jonathan J. Lee3,
- Lauren A. MacDonald5,
- Ammara Malik5,
- Kathleen T Hasselblatt6,
- Wenjing Li7,
- Hong Zhang1,
- Samuel J. Kaplan1,
- George F. Murphy3,
- Michelle S. Hirsch1,
- Joyce F. Liu5,
- Ursula A. Matulonis5,
- Kathryn L. Terry2,*,
- Christine G. Lian3,*, and
- Daniela M. Dinulescu1,*
- 1Department of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- 2Epidemiology Center, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- 3Department of Pathology, Division of Dermatopathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- 4Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea.
- 5Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts.
- 6Gynecologic Oncology Laboratory, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, Massachusetts.
- 7Department of Medicine, Division of Endocrinology, Brigham and Women's Hospital, Harvard Medical School Boston, Massachusetts.
- ↵*Corresponding Authors:
Daniela M. Dinulescu, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Ave. EBRC 401A, Boston, MA 02115. Phone: 617-732-5318; Fax: 617-264-5149; E-mail: ddinulescu{at}bwh.harvard.edu; Christine G. Lian, cglian{at}bwh.harvard.edu; and Kathryn L. Terry, kterry{at}bwh.harvard.edu
C.R. Getchell and E.T. McCarthy contributed equally to this article.
March 2018
Volume 24, Issue 6
Volume 24, Issue 6
Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer
Jump to section
Advertisement